TrivarX Limited (MDBIF)

OTCMKTS · Delayed Price · Currency is USD
0.0025
-0.0132 (-84.08%)
At close: Jan 6, 2026
Market Cap25.46M +390.5%
Revenue (ttm)675.98K +16.0%
Net Income-618.39K
EPS-0.00
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume337
Average Volume8,785
Open0.0025
Previous Close0.0157
Day's Range0.0025 - 0.0025
52-Week Range0.0025 - 0.0244
Beta0.30
RSI42.86
Earnings DateFeb 27, 2026

About TrivarX

TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023. TrivarX Limited was incorporated in 1987 and is based in Mount Lawley, Australia. [Read more]

Sector Healthcare
Founded 1987
Employees 6
Stock Exchange OTCMKTS
Ticker Symbol MDBIF
Full Company Profile

Financial Performance

In fiscal year 2025, TrivarX's revenue was 1.03 million, an increase of 16.00% compared to the previous year's 888,829. Losses were -943,231, -34.25% less than in 2024.

Financial numbers in AUD Financial Statements